Content of β-carotene in blood serum of human papillomavirus infected women with cervical dysplasias

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 5-6, 1996, Pages 309-313

  Kwaśniewska, Anna ^a   Tukendorf, Anna ^b   Semczuk, Marian ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

carotene level; Cervical intraepithelial neoplasia; Human papillomavirus

Indexed keywords

BETA CAROTENE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; LIFESTYLE; MIDDLE AGED; PAPILLOMA VIRUS; POLAND; RISK FACTOR; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; BETA CAROTENE; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLAND; RISK FACTORS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0030346893     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BASU J., PALAN P. R., VERMUND S. H., GOLDBERG G. L., BURK R. D. and ROMNEY S. L. (1991): Plasma ascorbic acid and β-carotene levels in women. Evaluated for HPV infection, smoking, and cervix dysplasia. Cancer Detect. Prev., 15, 165-170.
2. BRAUMANN T. and GRIMM L. H. (1981): Reversed-phase high-performance liquid chromatography of chlorophylls and carotenoids. Biochim. Biophys. Acta, 637, 8-17.
3. COMSTOCK G. W., BUSH T. L. and HELZLSOUER K. (1992): Serum retinol, β-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am. J. Epidemiol., 135, 115-121.
4. COX J. T., LORINCZ A. T., SCHIFFMAN M. H., SHERMAN M. E., CULLEN A. and KURMAN R. (1995): Human papillomavirus testing by Hybride Capture Appeares to be useful in triaging women with cytologic diagnosis of ASCUS. Am. J. Obstet. Gynecol., 35, 331-339.
5. EPSTEIN J. (1977): Effects of carotene on ultraviolet induced cancer formation in the hairless mouse skin. Photochem. Photobiol., 25, 211-213.
6. FERENCZY A. (1982): Carcinoma and other malignat tumors of the cervix. In BLAUSTEIN A.: Pathology of the female genital tract. Springer, New York, 184-222.
7. GISSMAN L. and SCHNEIDER A. (1986): The role of human papillomaviruses in genital cancer. In DE PAOLO G. F., RILKE and ZUR HAUSER H.: Herpes and papillomaviruses, Raven Press, New York, 31, 15-24.
8. HATCH K. D., GIULIANO A. R. and SCHNEIDER A. (1995): Antioxidant beta-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia. Free Radic. Biol. Med., 9 (suppl. 1), 18-31.
9. HARRIS R. W. C., FORMAN D., DOLL R., VESSEY M. P. and WALD N. J. (1986): Cancer of the cervix uteri and vitamin A. Br. J. Cancer, 53, 653-659.
10. KRAUSS R. M. (1988): The effects of oral contraceptives on plasma lipid and lipoproteins. Int. J. Fertil., 33, 35-42.
11. LA VECCHIA C., DECARLI A., FASOLI M., PARAZZINI F., FRANCESCHI S., GENTILE A. and NEGRI E. (1988): Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecol. Oncol., 30, 187-195.
12. LA VECCHIA C., FRANCESCHI S., DECARLI A., GENTILE A., FASOLI M., PAMPALLONA S. and TOGNONI G. (1984): Dietary vitamin A and the risk of invasive cervical cancer. Int. J. Cancer, 34, 319-322.
13. MATHEWS-ROTH M. (1982): Antitumor activity of beta-carotene, canthaxanthin, and phytoene. Oncology, 39, 33-37.
14. MELKERT P. W. J. and HOLTZ M. (1993): Prevalence of genital HPV-infection in women with and without abnormal cervical smears. Int. J. Cancer, 53, 919-934.
15. NIERENBERG, D. W., STUKEL T. A., BARON J, A., DAIN B. J., GREENBERG E. R. and The Skin Cancer Prevention Study Group (1989): Determinants of plasma levels of beta-carotene and retinol. Am. J. Epidemiol., 130, 511-521.
16. OKTABA W. (1980): Elementy statystyki matematycznej i metodyka doświadczalna. PWN, Warszawa.
17. PALAN P. R., MIKHAIL M. G., BASU J. and ROMNEY S. L. (1991): Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr. Cancer, 15, 13-20.
18. PALAN P. R., ROMNEY S. L., VERMUND S. H., MIKHAIL M. G. and BASU J. (1989): Effects of smoking and oral contraception on plasma β-carotene levels in healthy women. Am. J. Obstet. Gynecol., 161, 881-885.
19. PAPANICOLAU G. N. (1946): General survey of the vaginal smear and the use research and diagnosis. Am. J. Obstet. Gynecol., 51, 316-323.
20. RICHART R. M. (1973): Cervical intraepithelial necplasia. Pathol. Ann., 8, 310-328.
21. RYAN D. H. and STARR B. M. (1992): Vitamins in prevention and treatment of cancer. Contemp. Oncology, 1, 45-65.
22. SCHIFFMAN M. H. (1993): Summary of recent advances in our understanding of the natural history of HPV infection and cervical neoplasia. Contemp. Obstet. Gynecol., 38, 27-40.
23. SCHIFFMAN M. H. (1992): Recent progress in defining the epidemiology of human papillomavirus infection in cervical neoplasia. J. Natl. Cancer Inst., 84, 394-395.
24. SCHNEIDER A. and KOUTSKY L. A. (1992): Natural history and epidemiological features of genital HPV infection. In MUNOZ N., BOSCH F. X., SHAH K. V. and MEHEUS A.: The epidemiology of cervical cancer and human papillomavirus. International Agency for Research on Cancer, Lyon, 25-52.
25. SVRJANEN K. J. (1987): Papillomavirus infections and cancer. In: KOS L. K., SYRJANEN K. J. and GISSMMAN L. (eds.): Papillomaviruses. Springer, Heidelberg, 58-67.
26. ZUR HAUSEN H. and SCHNEIDER A. (1987): The role of papillomaviruses in human anogenital cancer. In HOWLEY P. and SALZMANN N. P. (eds.): The papovaviride, the papillomaviruses. Plenum Press, New York - London, 245-263.